Skip to main content
NIH funding notice PAR-16-330

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)

Closed on September 11, 2018.

Posted
June 15, 2016
Close date
September 11, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,385,506 in first-year total cost, median $440,413.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 MDCN-B (50)]12

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. HENRY M. JACKSON FDN FOR THE ADV MIL/MED1
  3. HUMAN BIOMOLECULAR RESEARCH INSTITUTE1
  4. MICHIGAN STATE UNIVERSITY1
  5. MISSISSIPPI STATE UNIVERSITY1
Competing awards under PAR-16-330 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Novel Antibody-Oxime Pairing to Reduce Circulating Organophosphate Levels.1U01NS112108-01THOMPSON, CHARLES MARKHUMAN BIOMOLECULAR RESEARCH INSTITUTE, CA$605,800ZRG1
2019Immunotherapy to Counteract Lethal Doses of Carfentanil1U01DA046323-01JANDA, KIMSCRIPPS RESEARCH INSTITUTE, THE, CA$520,662ZRG1
2019Targeted Therapeutic Approaches to Counteract Toxicity from Phosgene Oxime Skin Exposure1U01AR075470-01TEWARI-SINGH, NEERAMICHIGAN STATE UNIVERSITY, MI$478,508ZRG1
2019Improved Therapeutics for the Resurrection of the Aged Form of Acetylcholinesterase1U01NS112101-01HADAD, CHRISTOPHER M.OHIO STATE UNIVERSITY, OH$440,840ZRG1
2019Identification of lead compounds to topically treat sulfur mustard injury to reduce ocular damage and improve vision.1U01EY030406-01BAKER, SHENDASYNEDGEN, INC., CA$329,155ZRG1
2018Antiglutamatergic Therapy to Protect the Immature Brain Against Nerve Agents1U01NS102135-01A1BRAGA, MARIA F.HENRY M. JACKSON FDN FOR THE ADV MIL/MED, MD$449,430ZRG1
2018Anticholinergic and antiepileptic Therapies for Chlorine Toxicity1U01NS102101-01A1VERESS, LIVIA AGNESUNIVERSITY OF COLORADO DENVER, CO$439,986ZRG1
2018Identification of Novel Brain-penetrating Phenoxyalkyl Pyridinium Oxime Countermeasures1U01NS107127-01CHAMBERS, JANICE ELAINEMISSISSIPPI STATE UNIVERSITY, MS$427,511ZRG1
2018Cyanide/Azide Detoxification by New Cobalt Complexes and NO Donors1U01NS109793-01A1PEARCE, LINDA LPETERSON, JAMESUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$390,400ZRG1
2017TIE2 Activation for the Treatment of Chemical-Induced Acute Lung Injury1U01ES028187-01KONTOS, CHRISTOPHER DDUKE UNIVERSITY, NC$461,955ZRG1
2017Neurosteroids as a standard medical countermeasure for OP poisoning1U01NS102131-01GEE, KELVIN W.MCDONOUGH, JOHN H.UNIVERSITY OF CALIFORNIA-IRVINE, CA$434,581ZRG1
2017Targeting cardiopulmonary calpains to mitigate toxicity of halogen gases.1U01ES028182-01AHMAD, SHAMADELL'ITALIA, LOUIS J.UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$406,678ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.